Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.37 +0.01 (+0.10%) As of 03:02 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock OACC vs. DEA, ABL, GETY, AC, TINV, AACT, ORC, PLYM, FSNB, and ANNAShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Easterly Government Properties (DEA), Abacus Life (ABL), Getty Images (GETY), Associated Capital Group (AC), Tiga Acquisition (TINV), Ares Acquisition Co. II (AACT), Orchid Island Capital (ORC), Plymouth Industrial REIT (PLYM), Fusion Acquisition Corp. II (FSNB), and AleAnna Inc - Class A (ANNA). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Easterly Government Properties Abacus Life Getty Images Associated Capital Group Tiga Acquisition Ares Acquisition Co. II Orchid Island Capital Plymouth Industrial REIT Fusion Acquisition Corp. II AleAnna Inc - Class A Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Easterly Government Properties (NYSE:DEA) are both financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability and institutional ownership. Do insiders and institutionals have more ownership in OACC or DEA? 86.5% of Easterly Government Properties shares are owned by institutional investors. 8.1% of Easterly Government Properties shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media refer more to OACC or DEA? In the previous week, Easterly Government Properties had 14 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 16 mentions for Easterly Government Properties and 2 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.81 beat Easterly Government Properties' score of -0.37 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oaktree Acquisition Corp. III Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Easterly Government Properties 2 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral Do analysts prefer OACC or DEA? Easterly Government Properties has a consensus target price of $29.06, indicating a potential upside of 40.60%. Given Easterly Government Properties' stronger consensus rating and higher possible upside, analysts plainly believe Easterly Government Properties is more favorable than Oaktree Acquisition Corp. III Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oaktree Acquisition Corp. III Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Easterly Government Properties 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is OACC or DEA more profitable? Easterly Government Properties has a net margin of 6.25% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Easterly Government Properties' return on equity of 1.34% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A Easterly Government Properties 6.25%1.34%0.62% Does the MarketBeat Community favor OACC or DEA? Easterly Government Properties received 300 more outperform votes than Oaktree Acquisition Corp. III Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformOaktree Acquisition Corp. III Life SciencesN/AN/AEasterly Government PropertiesOutperform Votes30057.69% Underperform Votes22042.31% Which has stronger earnings and valuation, OACC or DEA? Easterly Government Properties has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AEasterly Government Properties$302.05M7.39$18.80M$0.19108.79 SummaryEasterly Government Properties beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesHolding Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$232.55M$473.79M$3.84B$7.93BDividend YieldN/A7.74%4.21%4.22%P/E RatioN/A2.4113.0418.54Price / SalesN/A54.241,692.12103.34Price / CashN/A69.0150.4934.62Price / BookN/A3.663.414.25Net IncomeN/A$35.22M$1.25B$248.18M7 Day Performance1.57%2.63%1.37%1.25%1 Month Performance2.07%4.42%12.85%3.76%1 Year PerformanceN/A24.20%12.94%5.28% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.37+0.1%N/AN/A$232.55MN/A0.00N/ANews CoveragePositive NewsDEAEasterly Government Properties2.5376 of 5 stars$8.15-0.5%$11.63+42.7%-31.0%$879.42M$302.05M45.2550Earnings ReportDividend CutAnalyst DowngradeNews CoverageABLAbacus Life3.4755 of 5 stars$8.24-0.7%$14.00+69.9%-29.6%$795.65M$111.92M-45.6482Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsGETYGetty Images2.8931 of 5 stars$1.93+4.1%$4.60+139.0%-48.2%$794.19M$939.29M16.041,700Short Interest ↑ACAssociated Capital Group2.7778 of 5 stars$35.02-0.7%N/A+10.3%$740.76M$13.18M16.9220Upcoming EarningsShort Interest ↓TINVTiga AcquisitionN/A$20.69+3.7%N/A+121.3%$713.81MN/A0.00N/AGap DownHigh Trading VolumeAACTAres Acquisition Co. IIN/A$11.25+0.2%N/A+6.0%$702.81MN/A0.00N/AUpcoming EarningsHigh Trading VolumeORCOrchid Island Capital4.6244 of 5 stars$7.31+5.4%$9.50+30.0%-14.3%$681.51M$54.41M12.182,018Earnings ReportAnalyst ForecastPLYMPlymouth Industrial REIT3.8563 of 5 stars$14.51-0.6%$21.20+46.1%-28.8%$661.17M$198.36M725.7540Earnings ReportUpcoming EarningsShort Interest ↓News CoveragePositive NewsFSNBFusion Acquisition Corp. IIN/A$10.49flatN/AN/A$655.63MN/A0.002High Trading VolumeANNAAleAnna Inc - Class AN/A$9.65-16.8%N/AN/A$642.49M$1.42M-482.50N/AGap Up Related Companies and Tools Related Companies Easterly Government Properties Competitors Abacus Life Competitors Getty Images Competitors Associated Capital Group Competitors Tiga Acquisition Competitors Ares Acquisition Co. II Competitors Orchid Island Capital Competitors Plymouth Industrial REIT Competitors Fusion Acquisition Corp. II Competitors AleAnna Inc - Class A Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OACC Stock Free OACC Stock Alerts